The Vanderbilt-Ingram Cancer Center, an NCI comprehensive cancer center, has a long-standing track record of true excellence in research by world-class investigators, in addition to being a leading cancer treatment facility. It is a top five matrix cancer center in National Cancer Institute funding, with yearly research funding exceeding $170M. The Center has seven highly competitive research programs including three basic science, three clinical, and one population-based. With very active clinical investigation, linked to all the research programs as well as a rapidly growing phase I program, there is ever-increasing demand for cutting edge biostatistical methodology for trial design and analysis of high dimensional data sets that results from genomic and proteomic approaches used to analyze tumor tissue as well as pre-clinical model systems. Also, the advent of next generation sequencing is producing large genomic and RNA-based data sets from clinical and bench-based investigation that require innovative analysis methods. The Center is also conducting large-scale epidemiologic investigations with well-defined cohorts and extensive biospecimen repositories providing opportunities for collaborative applied biostatistical research.
The Department of Biostatistics has 60 full-time biostatisticians. This is a unique opportunity for a biostatistician seeking a very significant leadership position in an environment known for its collaborative spirit and high impact science. For more information contact Frank Harrell, Chair, at f.harrell@vanderbilt.edu, and see http://biostat.mc.vanderbilt.edu.